When to use tranexamic acid for the treatment of major bleeding?
Tranexamic acid (TXA) is an antifibrinolytic agent originally developed for the management
of bleeding in the setting of postpartum hemorrhage (PPH). Over the last 15 years, there has …
of bleeding in the setting of postpartum hemorrhage (PPH). Over the last 15 years, there has …
The effect of perioperative tranexamic acid (TXA) in patients with calcaneal fractures: a meta-analysis and systematic review of randomized controlled trials
X Tang, K Li, F Zheng, Y He, Y Yang… - Journal of Orthopaedic …, 2023 - Springer
Background Calcaneal fractures are a common orthopedic disease, account for
approximately 2% of all bone fractures, and represent 60% of fractures of tarsal bones …
approximately 2% of all bone fractures, and represent 60% of fractures of tarsal bones …
Local Infiltration of Tranexamic Acid in Breast Reduction for Symptomatic Macromastia
G Nichols, E Andrade, M Gregoski… - Annals of plastic …, 2023 - journals.lww.com
Background With a surge of tranexamic acid (TXA) use in the plastic surgery community and
a constant demand for breast reduction for symptomatic macromastia, questions about the …
a constant demand for breast reduction for symptomatic macromastia, questions about the …